Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-07

FDA Approved: GLATOPA — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for GLATOPA, Sandoz's generic glatiramer acetate. This product is used for treating multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLATOPA (GLATIRAMER ACETATE)

Snippet

SUPPL AP for GLATOPA (GLATIRAMER ACETATE)